Several entries submitted by the Schreiner Group high-tech company convinced the FINAT judging panel this year: The Schreiner MediPharm and Schreiner ProTech business units each received two awards for their developments for the pharmaceutical and engineering-based industries respectively. The accol…

For a multinational pharmaceutical corporation, Schreiner MediPharm developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology…

International pharmaceutical corporation Pfizer opted for Schreiner MediPharm’s Needle-Trap needle protection label to equip the syringes for its epoetin biosimilar. This makes it the first medication for the treatment of anemia to be launched on the market with Needle-Trap–initially in Germany…

The countdown is on: On February 9, 2019, EU Directive 2011/62/EU will come into effect. It aims to stop illegal trade in falsified medicines. From then onwards, pharmaceutical manufacturers have to provide secondary packaging of all medicines placed on the market with an individual serial number as…

Schreiner MediPharm established a special service in a joint project with its customer Biotest AG: Late Stage Customization allows faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with the req…

Schreiner MediPharm has added a new version to its Flexi-Cap product family: Flexi-Cap for Clinical Trial Supplies (CTS). Flexi-Cap is an innovative security solution that irreversibly indicates the first opening of primary containers and thus prevents illegal filling and reuse of empty containers w…

Schreiner MediPharm has developed a novel marking solution for syringes: Pharma-Multi-Act. The label, together with the cap, is easy to open with one flick of the wrist, which makes it particularly user-friendly.  Pharma-Multi-Act also offers reliable and irreversible first-opening indication and m…

For a leading producer of anesthetics in China, Schreiner MediPharm developed a new version of the Pharma-Comb SL (Self-Lifting) label with a starter tab. The special label design is particularly easy to use on small vials allowing efficient and reliable marking of the medication while increasing pa…

During clinical trials it is important to neutralize investigational products to ensure that active drug and placebo cannot be distinguished from one another, in order to guarantee valid and compliant results. At the same time, there is a legal obligation to provide extensive product information in…

Schreiner MediPharm has further developed Flexi-Cap, its innovative first-opening indication security concept, for oncological applications: An additional cap protects the bottom of bottles or vials against glass breakage and surface contamination. Schreiner MediPharm will present the novelty as a p…